Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Terminated 2Withdrawn 1Recruiting 1Completed 1Active not recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Breast 2

Conditions

Breast Neoplasms 6Carcinoma, Intraductal, Noninfiltrating 2Breast Carcinoma In Situ 2Triple Negative Breast Neoplasms 1Lung Neoplasms 1Carcinoma, Non-Small-Cell Lung 1

Interventions

Specimen Handling 3Mastectomy, Segmental 2polyphenon E 1perflutren 1pasireotide 1palbociclib 1fezolinetant 1abemaciclib 1Yoga 1UAB 30 1Tea 1Tamoxifen 1Surgical Procedures, Operative 1Sugars 1Radiotherapy 1Radiation 1Naltrexone 1Mifepristone 1Lapatinib 1Hypericum extract LI 160 1Genotype 1Gefitinib 1Brachytherapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Terminated × Carcinoma, Intraductal, Noninfiltrating × Mastectomy, Segmental × Clear all
NCT00290654 2017-12-28

Internal Radiation Therapy After Lumpectomy in Treating Women With Ductal Carcinoma in Situ

Masonic Cancer Center, University of Minnesota

Phase 2 Terminated
45 enrolled 11 charts
Breast

Breast Carcinoma In Situ, Breast Neoplasms, Carcinoma, Intraductal, Noninfiltrating

NCT00082667 2013-02-25

Gefitinib Followed By Surgery in Treating Women With Ductal Carcinoma In Situ of the Breast

Vanderbilt-Ingram Cancer Center

Phase 2 Terminated
1 enrolled
Breast

Breast Carcinoma In Situ, Breast Neoplasms, Carcinoma, Intraductal, Noninfiltrating

Data powered by HemOnc (CC BY 4.0) Colophon âš¡